Study of the safety of hyper immune bovine milk and colostrum against covid-19
Not Applicable
- Conditions
- Covid-19 viral pneumonia.Pneumonia due to SARS-associated coronavirusJ12.81
- Registration Number
- IRCT20200927048849N1
- Lead Sponsor
- Isfahan university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Signing of consent form of the study
Free of underlying disease
Not having clinical signs of covid-19 infection
Exclusion Criteria
Diseased person
Not having underlying disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of clinical symptoms. Timepoint: From the first day of using until 14 days after that. Method of measurement: Questionnaire through phone interview.
- Secondary Outcome Measures
Name Time Method